Equities Research Analysts’ updated eps estimates for Thursday, February 15th:

Applied Materials (NASDAQ:AMAT) had its overweight rating reaffirmed by analysts at KeyCorp. KeyCorp currently has a $74.00 target price on the stock, up from their previous target price of $67.00.

Ares Capital (NASDAQ:ARCC) had its buy rating reiterated by analysts at National Securities. They currently have a $19.00 target price on the stock. The analysts wrote, “• For 4Q17, ARCC posted core NII/share of $0.38, a penny shy of our estimate but matching the quarterly dividend. We were, and are still, puzzled by what we see as a discounted valuation on ARCC shares. The market seemed to, for whatever reason, think that ARCC would not achieve dividend coverage despite acquiring ACAS for cash and stock, issuing a significant amount of shares, and having to recycle many lower yielding or non-yielding assets into its own originations. We think that as the company continues to make excellent progress in the recycling of these assets and ramps the SDLP that core NII will cover the dividend even absent the $10.0 million in fee waivers the external manager has granted the company for up to 10 quarters subsequent to the ACAS deal closing. This will likely be up a positive catalyst for shares, in our opinion.

• Ares announced that its SDLP program is being expanded to more than double in size to $6.4 billion from $2.9 billion with additional capital from Varagaon, ARCC, and a “leading global insurance company” being invested in the program that had a yield by cost of 14.5% as of 12/31/17. As a reminder, the SSLP loans were repurchased and the program wound down entirely in 2Q17. As of 4Q17, the SDLP was only 4.1% of the portfolio at cost and CLOs were 1.0%, leaving ARCC ample room to grow its 30% basket with the SDLP and bolster earnings.

• NAV/share improved to $16.65 from $16.49 Q/Q as sizable realized losses of $123.0 million (primarily pertaining to Infilaw Holdings) was offset by unrealized gains of $215.0 million largely from reversal of prior period depreciation and some positive marks on the portfolio.

• We are revising our 2018 core NII/share estimate to $1.63 from $1.61 and are rolling out our 2019 core NII/share estimate of $1.70.”

Antares Pharma (NASDAQ:ATRS) had its buy rating reissued by analysts at HC Wainwright.

Criteo (NASDAQ:CRTO) had its hold rating reissued by analysts at BMO Capital Markets. BMO Capital Markets currently has a $32.00 target price on the stock.

Cisco Systems (NASDAQ:CSCO) had its positive rating reiterated by analysts at Wells Fargo & Co. The firm currently has a $52.00 price target on the stock, up from their previous price target of $47.00.

Cisco Systems (NASDAQ:CSCO) had its buy rating reaffirmed by analysts at Jefferies Group LLC. The firm currently has a $48.00 target price on the stock.

Diamond Offshore Drilling (NYSE:DO) had its sell rating reissued by analysts at Jefferies Group LLC.

Dycom Industries (NYSE:DY) had its outperform rating reissued by analysts at Wells Fargo & Co. Wells Fargo & Co currently has a $125.00 price target on the stock, up from their previous price target of $108.50.

Equinix (NASDAQ:EQIX) had its buy rating reaffirmed by analysts at Credit Suisse Group AG. The firm currently has a $519.00 price target on the stock. The analysts wrote, “We expound on EQIX’s interconnection strategy in our 2018 Outlook, “The Cloud Has Four Walls.” EQIX also provided updated 2018 guidance with revenues/ adj. EBITDA/ AFFOS of $5.01bn/ $2.39bn/ $20.38 respectively. As such, we update our FY18/ FY19 revenues to $5.03bn/ $5.74bn (from $5.26bn/ $5.96bn) and decrease our FY18/ FY19 AFFOS to $20.82/ $24.33 (from $22.80/ $25.84), respectively. We lower our target price to $519 (from $524) to reflect the decrease in AFFOS in FY19. $800 Million Acquisition of Infomart Dallas: EQIX also announced its acquisition of Infomart Dallas. The facility is one of the largest U.S. interconnection hubs and currently home to four of the eight EQIX Dallas IBX data centers, which altogether support ~3,500 cabinets. This transaction adds four facilities to EQIX’s portfolio and the building generated ~$50mil of revenues in 2017 and expected to increase recurring revenues as a percentage of total revenues +45%.””

Gray Television (NYSE:GTN) had its buy rating reaffirmed by analysts at Benchmark Co.. They currently have a $21.00 target price on the stock. The analysts wrote, “We noted in our recent political primer that the Alaskan gubernatorial race has heated up once again, albeit not to the same degree, while Gray reaches the third largest number of toss- up/contested DMAs in our broadcast group, which bodes well for material upside. Change in Earnings Forecast Rating: Buy Current Price $15.25 Price Target $21.00 52-Wk Range $11.70 – $17.80 Shares Outstanding (mm) 73 Market Cap (mm) $1,106 Enterprise Value (mm) $2,837 Average Volume (000s) 811 Net Debt (mm) $1,731 Sector Weight Market Weight Daniel L. Kurnos, CFA 561-939-8262 [email protected] FY Dec Q1 Q2 Q3 Q4 Total P/E EV/EBITDA EPS 2017E $0.14A $0.97A $0.21A $0.22E $1.55E 10x 2018E $0.30E $0.48E $0.50E $0.75E $2.03E 8x 2019E $0.27E $0.52E $0.35E $0.34E $1.49E 10x EBITDA 2017E $64A $86A $73A $75E $297E 10x 2018E $76E $93E $94E $119E $382E 7x 2019E $73E $98E $81E $80E $331E 9x Gray Television, Inc.””

Intercept Pharmaceuticals (NASDAQ:ICPT) had its hold rating reaffirmed by analysts at Oppenheimer Holdings Inc..

Immutep (NASDAQ:IMMP) had its buy rating reiterated by analysts at Maxim Group. The firm currently has a $5.00 target price on the stock. The analysts wrote, “While we maintain a positive view on the LAG-3 space and the progress that Immutep is making to develop its LAG-3 pipeline, it is going to take more time and capital. Given the early stage of the trials in breast cancer and melanoma, we have extended our timelines to approval. Specifically, we now anticipate commercialization for IMP321 in breast cancer in 2021 (from 2020) in Europe and 2023 (from 2021) in the U.S. These changes in combination with other model adjustments result in a 12-month price target of $5, reduced from $7. In addition, we note that the company has ~$12M in cash on the balance sheet, which at the current burn rate of $3-4M per quarter is sufficient runway into 2H18, but we should expect to see a capital raise at some point this year.””

Interpublic Group of Companies (NYSE:IPG) had its neutral rating reiterated by analysts at Jefferies Group LLC.

Interpublic Group of Companies (NYSE:IPG) had its buy rating reaffirmed by analysts at BMO Capital Markets. The firm currently has a $27.00 price target on the stock.

Inditex (BME:ITX) had its buy rating reaffirmed by analysts at DZ Bank AG.

Laredo Petroleum (NYSE:LPI) had its hold rating reissued by analysts at Williams Capital. They currently have a $11.00 price target on the stock. The analysts wrote, “We reaffirm our Hold rang, but reduce our price target to $11 (from $13).””

Luxoft (NYSE:LXFT) had its overweight rating reissued by analysts at KeyCorp. They currently have a $56.00 price target on the stock, down from their previous price target of $66.00.

Mercadolibre (NASDAQ:MELI) had its overweight rating reissued by analysts at Piper Jaffray Companies. The firm currently has a $415.00 target price on the stock.

Metro (OTCMKTS:MTTRY) had its neutral rating reaffirmed by analysts at DZ Bank AG.

Newell Brands (NYSE:NWL) had its hold rating reiterated by analysts at Wells Fargo & Co. They currently have a $25.00 target price on the stock. The analysts wrote, “We recommend investors hold the stock but refrain from adding new money at this time since we see limited positive catalysts given: (1) Ongoing uncertainty surrounding who is going to run the company? Polk or Starboard/Jarden with likely disruptions regardless of the outcome; (2) Limited upside potential from Q4 results & CAGNY presentation given Q4 pre-announcement and mgmt’s diminished credibility; (3) Difficult fundamentals (tough topline comps for Elmer’s in 1H18 based on our analysis, continued retailer destocking pressures, Toys ‘R Us bankruptcy, slow category growth, etc); and (4) Limited return of capital to shareholders in the n.t. given high leverage. Bottom line – Despite what appears to be a relatively cheap valuation for NWL, we are incrementally more negative/cautious on the stock given likely disruptions, continued uncertainty and pressures on fundamentals. As such, we expect the stock could be range bound in the n.t.””

Sprouts Farmers Market (NASDAQ:SFM) had its outperform rating reiterated by analysts at Royal Bank of Canada. The firm currently has a $32.00 price target on the stock.

Tanger Factory Outlet Centers (NYSE:SKT) had its hold rating reaffirmed by analysts at Boenning Scattergood. The analysts wrote, “We continue to rate SKT Neutral as the company has a solid balance sheet, but the lack of underlying growth and development will result in poor earnings momentum during 2018.””

Tripadvisor (NASDAQ:TRIP) had its neutral rating reiterated by analysts at Piper Jaffray Companies. The firm currently has a $47.00 target price on the stock.

Vale (NYSE:VALE) had its hold rating reissued by analysts at Jefferies Group LLC. They currently have a $13.50 target price on the stock.

Veru (NASDAQ:VERU) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $5.00 price target on the stock.

Wayfair (NYSE:W) had its sell rating reaffirmed by analysts at Piper Jaffray Companies. The firm currently has a $112.00 price target on the stock.

Wix.Com (NASDAQ:WIX) had its overweight rating reaffirmed by analysts at Barclays PLC. The firm currently has a $80.00 price target on the stock.

Wix.Com (NASDAQ:WIX) had its neutral rating reaffirmed by analysts at Wedbush. Wedbush currently has a $75.00 target price on the stock, up from their previous target price of $65.00.

Receive News & Ratings for Applied Materials Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Materials Inc and related companies with MarketBeat.com's FREE daily email newsletter.